A K M Shafiul Kadir* , Saifa Saba Hossain


A K M Shafiul Kadir1*, Saifa Saba Hossain2

1 Quest Bangladesh Biomedical Research Center, Dhaka, Bangladesh.

2 Bangladesh Agricultural University, Mymensingh-2202, Bangladesh.

*Corresponding author:

A K M Shafiul Kadir

Affiliation: Quest Bangladesh Biomedical Research Center, Dhaka, Bangladesh.


ORCID: 0000-0002-3294-6541.

SCOPUS ID: 57859167000

Researcher ID: G-8486-2019

A R T I C L E  I N F O

Article Type: Research

Received: 17, Aug. 2023.

Accepted: 19, Sep. 2023.

Published: 15, Nov. 2023.




Amidst the aftermath of the unprecedented challenges of the COVID-19 pandemic, global health systems remain poised to tackle emerging diseases. Among these, dengue fever has emerged as a persistent concern in Southeast Asia, with Bangladesh at the forefront. Since its initial outbreak in 2000, dengue has followed the typical epidemic trajectory, marked by increasingly frequent and expansive outbreaks that have spread across Bangladesh. With nearly a quarter-century of dengue outbreaks in Bangladesh, the disease has undoubtedly become an emerging outbreak of the decade. Dengue, caused by the dengue virus (DENV) and primarily transmitted through Aides mosquitoes, affects millions worldwide annually. Most cases are mild, but severe dengue poses life-threatening risks. Bangladesh faces a persistent dengue burden due to urbanization, climate change, and high population density. An escalating outbreak in 2023 necessitates urgent action. Dhaka city is the epicenter, with around 80% of deaths and 64.5% of hospitalizations nationally. The government has designated 63 medical facilities to manage cases, including specialized Dengue cells. Efforts to control dengue vectors continue, but the unique climate supports transmission. Public awareness and preventive strategies are crucial. Dhaka city’s vulnerability emphasizes precise interventions. Dengue’s economic impact strains healthcare and households. Coordinated efforts are vital to combat dengue in Bangladesh and globally. The World Health Organization (WHO) plays a pivotal role in providing support and strategies for effective management and control.


Bangladesh; Dengue Outbreak; Economic Impact; Preventive Measures; Therapeutic Strategies.


  1. Umar TP, Kamal AL, Shafiul M, Mohammed YA, Setti MO. Healthcare system preparedness for the next pandemic beyond COVID-19 situation. 2022; 493–4.
  2. Kubra K, Shafiul Kadir AKM, Jobran AWM. Emergence and re-emergence of infectious diseases in South Asia: A call for action. Ann Med Surg. 2022 Dec; 84:104878.
  3. Dengue – Bangladesh [Internet]. Available from:
  4. Hossain MS, Noman A Al, Mamun SMA Al, Mosabbir A Al. Twenty-two years of dengue outbreaks in Bangladesh: epidemiology, clinical spectrum, serotypes, and future disease risks. Trop Med Health [Internet]. 2023; 51(1):37. Available from:
  5. Bangladesh Dengue Response Operation 2023 – DREF Operation (MDRBD031) – Bangladesh | ReliefWeb [Internet]. Available from:
  6. Dengue: Delay in hospitalization increases death risk | Prothom Alo [Internet]. Available from:
  7. Kayesh ME, Khalil I, Kohara M, and Tsukiyama-Kohara K. Increasing Dengue Burden and Severe Dengue Risk in Bangladesh: An Overview. Vol. 8, Tropical Medicine and Infectious Disease. 2023.
  8. Bhowmik KK, Ferdous J, Baral PK, Islam MS. Recent outbreak of dengue in Bangladesh: A threat to public health. Heal Sci Reports [Internet]. 2023 Apr 1; 6(4):e1210. Available from:
  9. Hossain MI, Alam NE, Akter S, Suriea U, Aktar S, Shifat SK, et al. Knowledge, awareness and preventive practices of dengue outbreak in Bangladesh: A countrywide study. PLoS One [Internet]. 2021 Jun 10; 16(6):e0252852. Available from:
  10. Wiwanitkit V. Unusual mode of transmission of dengue. J Infect Dev Ctries [Internet]. 2009 Nov 30; 4(01 SE-View Points):51–4. Available from:
  11. Palanichamy Kala M, St. John AL, Rathore APS. Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines. Curr Treat Options Infect Dis [Internet]. 2023; 15(2):27–52. Available from:
  12. For Healthcare Providers | Dengue | CDC [Internet]. Available from:
  13. Bardiot D, Koukni M, Smets W, Carlens G, McNaughton M, Kaptein S, et al. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. J Med Chem [Internet]. 2018 Sep 27; 61(18):8390–401. Available from:
  14. Islam S, Huq I. Economic Cost of Dengue: A Selective Case in Bangladesh. Int J Appl Econ Financ. 2020; 15(1):1–10.
  15. Uddin MA. Exploring Socio-Economic Impact of Chikungunya Fever in Dhaka: A Statistical Modeling Approach. Eur J Med Heal Sci. 2021; 2(6):103–10.